Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 16Genitourinary 2Gastrointestinal 2CNS 2Breast 2Thoracic 1Plasma cell 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1863Lung Neoplasms 1292Small Cell Lung Carcinoma 324Colorectal Neoplasms 273Breast Neoplasms 242Melanoma 221Neoplasms 215Ovarian Neoplasms 192Neoplasm Metastasis 182Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 150Stomach Neoplasms 141Head and Neck Neoplasms 121Carcinoma, Renal Cell 119Triple Negative Breast Neoplasms 109Esophageal Neoplasms 108Prostatic Neoplasms 106Endometrial Neoplasms 98Uterine Cervical Neoplasms 96Urinary Bladder Neoplasms 87Colonic Neoplasms 87Mesothelioma 86Mesothelioma, Malignant 80Carcinoma, Hepatocellular 74Brain Neoplasms 70Sarcoma 63Disease 62Adenocarcinoma of Lung 59Carcinoma, Transitional Cell 54Gastrointestinal Neoplasms 50

Interventions

atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Alveolar Soft Part × Thoracic × 1 year × Clear all
NCT06066138 2026-06-04

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
30 enrolled
DermatologicGastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Melanoma, Sarcoma, Alveolar Soft Part, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡